Ricoh Company, Ltd. has announced the development of an innovative 3D inkjet printing technology that combines full-colour capabilities with high mechanical strength and biocompatibility in printed resin components. This breakthrough technology addresses longstanding limitations in material jetting processes and opens new possibilities for custom manufacturing in healthcare and consumer applications.
The new technology specifically targets industries requiring both aesthetic appeal and functional performance, with initial implementations focused on dental applications. According to Ricoh, the system has already been adopted by Core Dental Lab Yokohama and is currently undergoing evaluation for clinical use.
Overcoming Traditional Material Jetting Limitations
Ricoh's development tackles two significant challenges that have historically limited material jetting applications: insufficient mechanical strength and restricted colour options. Traditional stereolithography (SLA) printing processes typically produce either robust single-colour parts or more fragile full-colour components.
The company's engineering team created a novel ink formulation that incorporates special fillers to enhance mechanical strength while maintaining the precise jettability required for high-resolution printing. This system uses high-strength clear and white inks to form the structural base of components, then adds highly concentrated yellow, magenta, and cyan inks to achieve full-colour capabilities.
This approach enables the production of parts that combine the aesthetic advantages of full-colour printing with the functional requirements of end-use components. The technology represents a significant advancement in material jetting, which has traditionally been limited to prototyping rather than production applications.
The new 3D Inkjet Printing Technology
A key feature of Ricoh's new 3D inkjet printing technology is the biocompatibility of its ink formulation. The materials have passed JIS T 10993-1 testing standards for medical devices, making printed components suitable for dental prosthetics and other applications requiring direct patient contact.
This biocompatibility certification significantly expands the potential application areas beyond visual prototypes to include functional medical devices. Ricoh identified dental prosthetics, eyeglass frames, and custom prosthetic components as primary target applications where the combination of colour customisation and mechanical performance offers particular value.
The scientific research underlying this technology has been published in The International Journal of Advanced Manufacturing Technology, providing peer-reviewed validation of Ricoh's approach. This publication demonstrates the company's commitment to advancing the fundamental science of additive manufacturing while developing commercial applications.
Market Availability and Future Expansion
The technology is currently available in Japan, with Core Dental Lab Yokohama serving as an early adopter in the dental sector. While not yet available in Europe or North America, Ricoh has indicated it is actively exploring expansion into these regions.
Ricoh's entry into the dental 3D printing space positions the company alongside other major manufacturers who have identified dentistry as a key market for additive manufacturing. However, Ricoh's approach through material jetting technology offers a distinctive alternative to the powder bed fusion and vat photopolymerization methods more commonly used in dental applications.
The company has not yet announced specific timelines for international expansion or provided details about the printing system's specifications and production capacity. However, the successful implementation in a commercial dental laboratory suggests the technology has reached a mature stage of development ready for practical applications.
By combining full-colour capabilities with mechanical performance and biocompatibility, Ricoh's new 3D inkjet printing technology represents a significant advancement in material jetting applications, potentially expanding the role of this printing method beyond prototyping into functional end-use parts for medical and consumer markets.
